There are 119 results for 'Key Finding'

Majority of key on-patent products have access initiatives, but these are limited in reach

From the 20 companies evaluated, the Index has identified 53 products that are critical candidates for companies’ access initiatives. The Index uses f...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/majority-of-key-on-patent-products-have-access-initiatives-but-these-are-limited-in-reach

On-patent products: how do pharmaceutical companies use pricing, licensing and donations to improve access to key medicines?

Low- and middle-income countries are home to the majority of the world’s poorest people. Whether medicines, vaccines and other products reach the peop...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/on-patent-products-how-do-pharmaceutical-companies-use-pricing-licensing-and-donations-to-improve-access-to-key-medicines

On-patent products: how do pharmaceutical companies use pricing, licensing and donations to improve access to key medicines?

Low- and middle-income countries are home to the majority of the world’s poorest people. Whether medicines, vaccines and other products reach the peop...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/on-patent-products-how-do-pharmaceutical-companies-use-pricing-licensing-and-donations-to-improve-access-to-key-medicines

World AIDS Day: Foundation and CHAI publish paper on licensing ARVs to improve access

Approximately 20.9 million people living with HIV/AIDS now have access to treatment – out of an estimated 36.7 million people worldwide living with th...

https://accesstomedicinefoundation.org/news/world-aids-day-foundation-and-chai-publish-paper-on-licensing-arvs-to-improve-access

Who we are

The Access to Medicine Foundation is an independent non-profit organisation. We analyse how the world's largest pharmaceutical companies are addressin...

https://accesstomedicinefoundation.org/about-us/who-we-are

Commits to registering new products in poorer countries in 12 months

Parallel dossier preparation to facilitate faster registration.

https://accesstomedicinefoundation.org/access-to-medicine-index/best-innovative-practices/commits-to-registering-new-products-in-poorer-countries-in-12-months

Jayasree K. Iyer to speak at Novartis Social Business stakeholder dialogue

On November 21, Jayasree K. Iyer will speak at the Novartis Social Business stakeholder dialogue in Basel. The goal of the meeting is to bri...

https://accesstomedicinefoundation.org/events/jayasree-k-iyer-to-speak-at-novartis-social-business-stakeholder-dialogue

The Foundation convenes company workshop on best practices and impact in London

The Foundation will bring together pharmaceutical companies measured in the 2018 Access to Medicine Index for a workshop on Best Practices & Impact. T...

https://accesstomedicinefoundation.org/events/the-foundation-convenes-company-workshop-on-best-practices-and-impact-in-london

Reaching the 2 billion: The Japanese pharmaceutical industry and access to medicine

A commentary by Jayasree K. Iyer and Danny Edwards, on the increasing orientation of Japan towards global health issues, and the growing contribution...

https://accesstomedicinefoundation.org/publications/reaching-the-2-billion-the-japanese-pharmaceutical-industry-and-access-to-medicine

Strong transparency on where products are registered

Only company to publish full details of the registration status of its products. 

https://accesstomedicinefoundation.org/access-to-medicine-index/best-innovative-practices/strong-transparency-on-where-products-are-registered